Synteract

Interoffices EU Parliament - Avenue des Arts 56

1000 Brussel

BE

Synteract

Foundation date

29/02/1996

Sector

#Biotechnology / R&D Services

Subsector

In February 2013, San Diego-based Synteract acquired Munich-based Harrison Clinical Research – and expanded our services and strength to the Power of Two – two excellent CROs that, together as one, deliver international, full-service clinical trial services.

Upcoming events

Latest news

  • Latest field trials validate strength of Biotalys’ first biocontrol Evoca

    Thursday May 19th 2022

  • Belgian biotech in European Top-3 despite turbulent times

    Wednesday May 18th 2022

  • KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus

    Wednesday May 18th 2022